Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

An Ophthalmic Safety Study in Patients With Breast Cancer

ClinicalTrials.gov ID: NCT06767462

Public ClinicalTrials.gov record NCT06767462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 4:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre Study Assessing Ophthalmic Safety in Patients With Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess ophthalmic health in parallel cohorts of patients with breast cancer

Study identification

NCT ID
NCT06767462
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2025 (Actual)
Primary completion
Apr 9, 2027 (Estimated)
Completion
Apr 9, 2027 (Estimated)
Last update posted
Jun 16, 2026

2025 – 2027

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Research Site La Jolla California 92093 —
Research Site Palo Alto California 94304 —
Research Site Iowa City Iowa 52242 —
Research Site Winston-Salem North Carolina 27104 —
Research Site Clairton Pennsylvania 15025 —
Research Site Pittsburgh Pennsylvania 15219 —
Research Site Sioux Falls South Dakota 57105 —
Research Site Bartlett Tennessee 38133 —
Research Site Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06767462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2026 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06767462 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →